CareDx
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CareDx and other ETFs, options, and stocks.About CDNA
CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products.
CDNA Key Statistics
Stock Snapshot
CareDx(CDNA) stock is priced at $14.82, giving the company a market capitalization of 762.23M. It carries a P/E multiple of 13.86.
On 2025-11-06, CareDx(CDNA) stock moved within a range of $14.75 to $16.97. With shares now at $14.82, the stock is trading +0.5% above its intraday low and -12.7% below the session's peak.
Trading activity shows a volume of 440.04K, compared to an average daily volume of 1.29M.
Over the past 52 weeks, CareDx(CDNA) stock has traded between a high of $26.37 and a low of $10.96.
Over the past 52 weeks, CareDx(CDNA) stock has traded between a high of $26.37 and a low of $10.96.
CDNA News
The U.S. stock market recently experienced a rebound, with major indices such as the Nasdaq, Dow Jones Industrial Average, and S&P 500 closing higher amid a rec...
CareDx Inc ((CDNA)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Pr...
William Blair analyst Andrew Brackmann has reiterated their neutral stance on CDNA stock, giving a Hold rating on November 1. Elevate Your Investing Strategy: T...
Analyst ratings
56%
of 9 ratingsMore CDNA News
CareDx Inc ( (CDNA) ) has released its Q3 earnings. Here is a breakdown of the information CareDx Inc presented to its investors. Elevate Your Investing Strate...
Earnings Call Insights CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches Nov. 04, 2025 10:17 PM ET CareDx, Inc (...
Reports Q3 revenue $100.1M, consensus $95.3M. “We achieved record-setting third quarter 2025 financial results, a testament to our market leadership that has be...